BioSpace News Archive

Cloud Pharmaceuticals, Inc., announced today they have entered into drug discovery collaboration with GlaxoSmithKline(GSK).

The d.health Summit will convene thought leaders across healthcare, finance, technology and policy on Wednesday, June 6 at the State Room in Boston, MA.

More than half of all children globally - over 1.2 billion - are threatened by widespread poverty, conflict or discrimination against girls, a new report by Save the Children has found.

The National Organization for Rare Disorders (NORD) today launched RareInsights™.

Children who undergo surgery for congenital heart disease have lower survival rates by three years of age if there are specific problems during fetal development.

Don Kania, Ph.D., has been appointed to the Board of Directors of Aldevron

Close to 400 guests were on hand at the Caisse de dépôt et placement du Québec for the 5th edition of the Audacious fundraising event, organized by the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and hosted by Stéphan Bureau.

Pfizer Inc. announced that the United States (U.S.) Food and Drug Administration (FDA) approved XELJANZ® (tofacitinib) 10 mg twice-daily (BID) for at least eight weeks, followed by XELJANZ 5 mg BID or 10 mg BID, for the treatment of adult patients in the U.S. with moderately to severely active ulcerative colitis (UC).

Streamline Health Solutions, Inc. announced it signed a contract with a large West-Coast based academic hospital for Streamline Health eValuator.

Array BioPharma Inc. announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2018 Global Healthcare Conference.